## Why Folate deficiency is right Anencephaly, as shown at **A** (absent cranial vault above the orbits), results from failure of closure of the rostral neuropore around days 23–26 post-conception. The clinical anchor explicitly identifies folate deficiency as the **most important MODIFIABLE risk factor** for neural tube defects, including anencephaly. The patient's lack of periconceptional folic acid supplementation and irregular dietary intake directly correlate with this preventable cause. ACOG guidelines recommend 400 micrograms daily for all women of reproductive age, started at least one month before conception and continued through the first trimester, with 4 mg/day for high-risk women. ## Why each distractor is wrong - **Maternal diabetes mellitus**: While maternal diabetes is a recognized risk factor for neural tube defects, it is NOT the most important modifiable factor. Folate deficiency is explicitly identified as the primary modifiable risk factor in the clinical anchor and ACOG guidelines. - **Maternal hyperthermia in early pregnancy**: Although maternal hyperthermia in early pregnancy is listed as a risk factor, it is less commonly preventable and less frequently emphasized than folate deficiency in clinical practice and guidelines. - **MTHFR C677T polymorphism**: This is a genetic polymorphism affecting folate metabolism, not a modifiable risk factor. It is a non-modifiable predisposition that cannot be changed through intervention. **High-Yield:** Folate deficiency is the most important MODIFIABLE risk factor for anencephaly and other neural tube defects; periconceptional folic acid supplementation (400 mcg daily, or 4 mg for high-risk women) is the cornerstone of prevention. [cite: ACOG Practice Bulletin: Neural Tube Defects; CDC Folic Acid Recommendations]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.